Search

everythinglearnresearchcommunity

for

Search:↓

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Talquetamab may cause hair loss and skin issues.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Upadacitinib effectively treats severe alopecia areata and is safe.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Guselkumab significantly improves quality of life for people with moderate to severe psoriasis.